S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                  4141--A
 
                        2023-2024 Regular Sessions
 
                           I N  A S S E M B L Y
 
                             February 10, 2023
                                ___________
 
 Introduced  by M. of A. FORREST, RAGA, GALLAGHER, SHRESTHA, GONZALEZ-RO-
   JAS, ARDILA, ALVAREZ, DARLING, AUBRY, SIMON, COLTON, BURDICK, MAMDANI,
   CHANDLER-WATERMAN, MITAYNES, MEEKS, STECK, KELLES, BLUMENCRANZ, DeSTE-
   FANO,  WALKER,  SEPTIMO,  TAPIA,  TAYLOR,  THIELE,  ANDERSON,   TAGUE,
   BENDETT, HYNDMAN, DICKENS, DURSO, SIMONE, EPSTEIN, CRUZ, DAVILA, COOK,
   SHIMSKY,  LUNSFORD,  BORES, CURRAN, LEVENBERG, FLOOD, MAHER, JACOBSON,
   BURGOS, HUNTER, CUNNINGHAM, RAJKUMAR, CARROLL, SANTABARBARA,  JACKSON,
   CLARK,  REYES  -- read once and referred to the Committee on Insurance
   -- recommitted to the Committee on Insurance in accordance with Assem-
   bly Rule 3, sec. 2 --  committee  discharged,  bill  amended,  ordered
   reprinted as amended and recommitted to said committee
 
 AN ACT to amend the insurance law, in relation to prohibiting cost shar-
   ing for insulin
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. Subparagraph (B) of paragraph 15-a  of  subsection  (i)  of
 section  3216  of the insurance law, as amended by section 1 of part DDD
 of chapter 56 of the laws of 2020, is amended to read as follows:
   (B) Such coverage may be subject to annual deductibles and coinsurance
 as may be deemed appropriate by the superintendent and as are consistent
 with those  established  for  other  benefits  within  a  given  policy;
 provided  however, [the total amount] that [a covered person is required
 to pay out of pocket for] covered prescription insulin drugs  shall  [be
 capped  at  an  amount  not to exceed one hundred dollars per thirty-day
 supply, regardless of the amount or type of insulin needed to fill  such
 covered  person's  prescription  and regardless of the insured's] NOT BE
 SUBJECT TO A deductible, copayment, coinsurance or any other cost  shar-
 ing requirement.
   § 2. Subparagraph (B) of paragraph 7 of subsection (k) of section 3221
 of  the insurance law, as amended by section 2 of part DDD of chapter 56
 of the laws of 2020, is amended to read as follows:
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD02649-03-4
              

 A. 4141--A                          2
 
   (B) Such coverage may be subject to annual deductibles and coinsurance
 as may be deemed appropriate by the superintendent and as are consistent
 with those  established  for  other  benefits  within  a  given  policy;
 provided  however, [the total amount] that [a covered person is required
 to  pay  out of pocket for] covered prescription insulin drugs shall [be
 capped at an amount not to exceed one  hundred  dollars  per  thirty-day
 supply,  regardless of the amount or type of insulin needed to fill such
 covered person's prescription and regardless of the  insured's]  NOT  BE
 SUBJECT  TO A deductible, copayment, coinsurance or any other cost shar-
 ing requirement.
   § 3. Paragraph 2 of subsection (u) of section 4303  of  the  insurance
 law,  as  amended  by section 3 of part DDD of chapter 56 of the laws of
 2020, is amended to read as follows:
   (2) Such coverage may be subject to annual deductibles and coinsurance
 as may be deemed appropriate by the superintendent and as are consistent
 with those  established  for  other  benefits  within  a  given  policy;
 provided  however, [the total amount] that [a covered person is required
 to pay out of pocket for] covered prescription insulin drugs  shall  [be
 capped  at  an  amount  not to exceed one hundred dollars per thirty-day
 supply, regardless of the amount or type of insulin needed to fill  such
 covered  person's  prescription  and regardless of the insured's] NOT BE
 SUBJECT TO A deductible, copayment, coinsurance or any other cost  shar-
 ing requirement.
   § 4. This act shall take effect January 1, 2025 and shall apply to any
 policy  or contract issued, renewed, modified, altered, or amended on or
 after such date.